CAS: 2097938-69-5 - 4-[7-(4-Chlorophenyl)-1,3,4,8,9,10,10a,11a-octahydro-9,9-dimethyl-2H,6H-pyrazino[2,1-b][1,3]benzoxazin-2-yl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
Fórmula:C45H48ClN7O8S
InChI:InChI=1S/C45H48ClN7O8S/c1-45(2)22-36(29-3-5-31(46)6-4-29)37-26-52-16-15-51(27-42(52)61-41(37)23-45)32-7-9-35(40(20-32)60-33-19-30-11-14-47-43(30)49-25-33)44(54)50-62(57,58)34-8-10-38(39(21-34)53(55)56)48-24-28-12-17-59-18-13-28/h3-11,14,19-21,25,28,41-42,48H,12-13,15-18,22-24,26-27H2,1-2H3,(H,47,49)(H,50,54)
Clave InChI:InChIKey=YOPHZZVJJKWTNO-UHFFFAOYSA-N
SMILES:O=C(NS(=O)(=O)C1=CC=C(NCC2CCOCC2)C(=C1)N(=O)=O)C3=CC=C(C=C3OC=4C=NC=5NC=CC5C4)N6CCN7CC8=C(C=9C=CC(Cl)=CC9)CC(C)(C)CC8OC7C6
- Sinónimos:
- Benzamide, 4-[7-(4-chlorophenyl)-1,3,4,8,9,10,10a,11a-octahydro-9,9-dimethyl-2H,6H-pyrazino[2,1-b][1,3]benzoxazin-2-yl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-
- 4-[7-(4-Chlorophenyl)-1,3,4,8,9,10,10a,11a-octahydro-9,9-dimethyl-2H,6H-pyrazino[2,1-b][1,3]benzoxazin-2-yl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Venetoclax Impurity 1 ( 3,3'-Oxy-Venetoclax, Metabolite M27) REF: 4Z-V-064003CAS: 2097938-69-5 | - - - | A consultar | Mar 10 Dic 24 | |
Venetoclax-M27 REF: TR-V121010CAS: 2097938-69-5 | - - - | 36.970,00 € | Vie 10 Ene 25 | |
Venetoclax-M27 REF: 3D-XID93869CAS: 2097938-69-5 | Min. 95% | A consultar | Lun 13 Ene 25 |
Venetoclax Impurity 1 ( 3,3'-Oxy-Venetoclax, Metabolite M27)
Ref: 4Z-V-064003
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Venetoclax-M27
Producto controladoRef: TR-V121010
25mg | 36.970,00 € |
Venetoclax-M27
Ref: 3D-XID93869
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |